Abstract
COMPARATIVE STUDY OF MARKETED IBUPROFEN TABLET

Jitendra Gupta, Eshan Pathak, Gazi Md. Talha, Jagdish Kshirsagar, Gaurav Kumar, Dr. Jagdish Chandra Rathi and Devendra Dhariwal*

ABSTRACT

Generic medicine is a pharmaceutical product that can be interchangeable with the innovator medicine. Generic medicine is the same as its corresponding innovator medicine in terms of quality, safety, efficacy, strength, dosage form, route of administration and intended use. However, there are misperceptions that generic medicines are less effective than branded drugs and/or generic drugs are poor quality as compared to brand medicines by health care providers and patients. There are many pharmaceutical companies and distribution channels of drugs worldwide. Unfortunately, circulation of poor quality drug products in the international market increase significantly as a result of ineffective regulation of manufacturing and trading of pharmaceutical products. Therefore, the manufacturing, distribution, storage and use of drugs need to be regulated authorized regulatory institutions. The quality of a pharmaceutical product is essential to ensure the safety of the patients. Different parameters of quality control of pharmaceutical products can guarantee the quality and bioavailability and optimal therapeutic activity. Therefore, the present study was undertaken with the aim of assuring the quality of ibuprofen tablets available in the Indian drug market.

Keywords: Generic medicine, Innovator medicine, Pharmaceutical product, Ibuprofen.


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: MARCH ISSUE PUBLISHED

    MARCH 2024 Issue has been successfully launched on 1 MARCH 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT